◆ 会议时间：2026年4月22-25日
◆ 会议地点：土耳其 伊斯坦布尔

◆ 会议简介：

2026年第35届亚太肝脏研究协会(APASL)年会将于2026年4月22-25日在土耳其伊斯坦布尔举行，会议由亚太肝脏研究协会(APASL)组织。APASL年会(亚太肝病年会)是亚太地区肝病学领域最具影响力的学术会议，大会科学计划涵盖肝脏学的所有方面，是与会者分享经验、知识和造福亚太地区人民的重要平台。大会组委会正在制定一项全面而又令人兴奋的科学计划，以反映当前最先进的技术和最具争议性的问题；众多世界知名的演讲者和代表将分享他们的专业知识、卓越成就和创新理念。

亚太肝脏研究协会（APASL）成立于1978年，是全球领先的致力于肝病研究和治疗的协会之一，是奉行标准与专业，为亚太地区数百万肝病患者研究和改进治疗方法的最大科学机构。APASL的主要目标是推动肝病学的最新科学发展与教育，交流信息和发展共识，鼓励肝脏病学的医学实践，协调区域内科学家和临床医生之间的科学研究；APASL定期召开科学教育研讨会/会议，由专家讲者宣通过高质量的科学技术报告呈现肝脏疾病热点话题中的最新数据，为参与者提供一个交流研究、讨论成果和与同事互动的平台。

APASL年会将为与会者提供高质量的科学教育内容，由一流的研究人员和临床医生报告涵盖肝病各个方面的最新信息宣。会议将为各机构、学术单位、企业、协会、非营利组织和其他相关部门提供一个交流与合作的途径，是为所有人分享我们在肝病方面的观点、价值观、经验和做法的最佳机会，如病毒性肝炎，肝癌，非酒精性脂肪性肝炎(NASH)，肝衰竭，门静脉高压症，酒精性肝病，肝移植，小儿肝病、肝脏放射学以及其它主题等。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）.

The 35th Conference of the Asian Pacific Association for the Study of the Liver - APASL 2026

会议时间/Date:
April 22-25, 2026

会议地点/Venue:
İstanbul Lütfi Kırdar International Convention and Exhibition Centre (İstanbul, Türkiye)

大会主题/Theme：

大会官方语言/Official Language：
English

主办单位/Hosted & Organized by：
Asian Pacific Association for the Study of the Liver (APASL)

摘要征文投稿/Call for Abstract：

Call for Abstracts：
July 21, 2025, Monday

Abstract Submission Deadline
November 24, 2025, Monday

Abstract Notifications
Mid-January 2026

点此提交摘要>>>

ABSTRACT SUBMISSION GUIDELINES

The scientific committee reminds attendees that the material deemed appropriate for presentation should have the following characteristics:

• Original and new scientific work
• Chosen abstracts will be presented as a poster presentation
• Outstanding abstracts will be considered for oral presentation

Abstracts submitters must pay attention to the following:

• It is the authors' responsibility to submit a correct abstract without any typo mistakes. There will be no editing process on the abstracts, and all accepted abstracts will be published as typed by the submitters. Therefore, please make sure to preview your abstract before submitting it for any typing errors, wrong spelling/writing of the institutions and/or author names, mis-ordering of the authors, etc
• Generic names for pharmaceuticals, biologic and medical devices should be used in place of trade names. Trade names should only be used if equivalent products from multiple manufacturers are being compared. Capitalize all trade names.
• Overly commercial abstracts will not be accepted.
• Only the accepted abstracts with registered presenters will be included in the scientific program and in the abstracts' book, the supplement of the Hepatology International Journal.
• Accepted and presented abstracts will be published in the "Hepatology International Journal”. By submitting an abstract, the authors consent to giving permission to publish their abstracts in the abstract publication, supplement of the Hepatology International Journal.

Abstract Submission Guidelines

• All abstracts must be submitted in English.
• Abstract submission system contains steps and abstracts can be submitted following these steps:
• Step 1 - Author(s): Enter the Name, Last Name, Title/Position, Department, Affiliation/Institution, City and Country information for all authors, and select the Presenting Author here.
• Submissions may have up to 10 authors and the presenting author needs to be selected in the system. If you have more authors of your abstract, please contact the Congress Organizing Secretariat.
• Enter the presenting author's contact details. Avoid any typo mistakes here, since entering especially the email address is crucial as all communication regarding the abstracts will be made through this email address.
• Step 2 - Categories: Select the abstract category amongst the listed categories. Please click here to reach the Main Topics. If none of these topics fit for your study, please use the topic "Other”.
• Step 3 - Presentation: Select your preferred presentation type amongst the options of Oral Presentation / E-Poster Presentation / No Preference. Chosen abstracts will be presented as e-poster presentation, and outstanding abstracts will be considered for oral presentation. Kindly note that the Scientific Committee reserves the right to change the presentation type according to the scientific program structure.
• Step 4 - Abstract: Abstract title, abstract text and keywords can be submitted in this section.
• Abstract titles must be limited to 30 words including spaces, typed in Lower case while the initial of the first word is written capital. The titles should define the topic and must NOT contain any abbreviations and/or any industry-specific words (eg. company or products names, etc).
• Abstract text excluding the authors and titles must be limited to 400 words including spaces under the below-given four (4) headings:
  • Background / Hypothesis
  • Materials and Methods
  • Results
  • Conclusions
• Enter keywords as per your preference while separating them by using comma (,).
• Generic names for pharmaceuticals, biologic and medical devices should be used in place of trade names. Trade names should only be used if equivalent products from multiple manufacturers are being compared. Capitalize all trade names.
• Step 5 - Upload File: You may upload tables, graphs or images; however, kindly note that these won't be included in the publication as only texts of abstracts will be published. Please upload tables, graphs or images as pdf or word files through this section. If you don't have any tables, graphs or images, you can skip uploading.
• Please make sure to save your work before logging off. You can save your work by clicking on the "Save and Preview" button. After saving, you'll be directed to the main page of abstract submission system where you can preview your abstract(s), and submit them.
• As edits are not allowed after submitting your abstract, please make sure to complete any edits and revisions before submitting your abstract.
• Make sure to submit your abstract before the abstract submission deadline of November 24, 2025.

Review Process and Acceptance Letters

All submitted abstracts will be scored and passed through a review process after the submission closes. The notification letters for the acceptance of the abstracts will be sent in January 2026.

Registration of Abstract Presenters

Kindly note that submitting an abstract does not constitute registration for the congress.

Presenting authors of accepted abstracts must register for the congress latest by February 2, 2026. Failure to do so will result in exclusion from the scientific program and all relevant publications.

Publication of Abstracts

All accepted and presented abstracts of the APASL 2026 Istanbul congress will be published in the supplement of the Hepatology International Journal with journal impact factor of 6,1 (2024) and 5-year journal impact factor of 6,5 (2024).

Awards

Specific awards will be granted for selected, outstanding abstracts.

WELCOME MESSAGE

We are thrilled to invite you to the 35th Annual Meeting of the Asian Pacific Association for the Study of the Liver (APASL 2026), taking place from April 22-25, 2026, at the İstanbul Lütfi Kırdar International Convention and Exhibition Centre. This event will bring together renowned experts, professionals, and researchers from across the globe to explore the latest developments and breakthroughs in liver disease and hepatology.

We are eagerly looking forward to welcoming you to İstanbul, where world-class science, collaboration, and a rich cultural experience await.

APASL 2026 ISTANBUL ORGANIZING COMMITTEE

• Prof. Dr. Necati Örmeci
  APASL 2026 President
• Dr. A. Kadir Dökmeci
  APASL 2026 Honorary President
• Prof. Dr. Hakan Şentürk
  APASL 2026 Scientific Committee Chair
• Prof. Dr. Mehmet Demir
  APASL 2026 Secretary General
• Prof. Dr. Gülseren Seven
  APASL 2026 Deputy Secretary General
• Prof. Dr. Mehmet Asil
  APASL 2026 Deputy Secretary General
• Prof. Dr. Murat Kekilli
  APASL 2026 Deputy Secretary General

注册费：

Registration Fee includes;

• Access to all congress sessions
• Access to the exhibition area
• Congress materials (eg. name badges, certificate of attendance, any printed or digital materials to be produced for participants, etc.)
• Refreshments (coffee breaks) during the congress program
• Access to the Welcome Reception

Cancellation Policy - Registration:

Cancellation requests must be received in writing by the APASL 2026 Istanbul - Registration Secretariat (DEKON Congress & Tourism) via e-mail to registration@apasl2026istanbul.org, and the below cancellation policy will apply.

• Cancellation requests received before or on 29 December 2025, full refund will be provided less a 20% administration fee.
• Cancellation requests received on or after 30 December 2025, no refund will be provided, and only name changes can be done after this deadline.

Note that registration refunds will be processed within 30 days after the end of APASL 2026 Istanbul, bank charges will be deducted from the refund.

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。